Search This Blog

Wednesday, February 26, 2020

Editas Medicine EPS misses by $0.81, misses on revenue

Editas Medicine (NASDAQ:EDIT): Q4 GAAP EPS of -$0.74 misses by $0.81.
Revenue of $12.28M (+101.3% Y/Y) misses by $32.33M.
Press Release
https://seekingalpha.com/news/3546023-editas-medicine-eps-misses-0_81-misses-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)